Conditions: Schizophrenic Disorders Schizoaffective Disorder
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 931
Healthy volunteers: no

Brief summary:
This is a long-term, open-label clinical study designed to enable longer-term treatment of patients completing other clinical studies with intramuscular olanzapine depot.

Key objectives of the study are to:

* Determine how well intramuscular (IM) olanzapine depot works during long-term treatment,
* Evaluate the safety and tolerability of IM olanzapine depot during long-term treatment,
* Determine the blood levels of IM olanzapine depot in patients during long-term treatment

Detailed description:

Arms:
arm 1: Intramuscular (IM) olanzapine depot flexible dosing and flexible interval

Interventions: intervention 1: Intramuscular olanzapine depot
Intervention descriptions: intervention 1: 45-405 milligram (mg), intramuscular injection, on a 2-, 3-, or 4-week interval.

Protocol document: